SENS (Senseonics Holdings) Research & Development: $32.90 Mil (TTM As of Mar. 2026)


SENS Senseonics Holdings Inc SENS
56 GF Score
Price $5.72
GF Value $13.99
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Senseonics Holdings Research & Development?

Senseonics Holdings SENS +6.12% 56 Research & Development is $32.90 Mil as of Mar. 2026. GuruFocus rates SENS with a GF Score™ of 56/100 and a GF Value™ of $13.99 (Possible Value Trap). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Senseonics Holdings's Research & Development for the three months ended in Mar. 2026 was $8.61 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $32.90 Mil.

Senseonics Holdings  (NAS:SENS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Senseonics Holdings Research & Development Related Terms

Senseonics Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Senseonics Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senseonics Holdings Research & Development Chart

Senseonics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.22 39.72 48.75 41.14 31.59

Senseonics Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.30 7.72 7.76 8.82 8.61
SENS
56GF Score
Senseonics Holdings Inc SENS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Senseonics Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $32.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $32.90 Mil mean?
Senseonics Holdings (SENS) has a Research & Development of $32.90 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Senseonics Holdings and its competitors.
Is Senseonics Holdings' Research & Development too high?
Senseonics Holdings' current Research & Development is $32.90 Mil. Overall, Senseonics Holdings has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senseonics Holdings' Research & Development compare to CV and DCTH?
Senseonics Holdings' Research & Development of $32.90 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Senseonics Holdings and its competitors. Senseonics Holdings's current Research & Development is $32.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senseonics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Senseonics Holdings (SENS) is currently considered Possible Value Trap. The stock's GF Value™ is $13.99, compared to a current price of $5.72 — trading 59.1% below its estimated fair value. The current Research & Development is $32.90 Mil. Senseonics Holdings' overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Senseonics Holdings (SENS), the current Research & Development is $32.90 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Senseonics Holdings (SENS) Overvalued in 2026?

Based on GuruFocus' analysis, Senseonics Holdings stock appears to be undervalued. The current stock price of $5.72 is trading 59.1% below its estimated GF Value™ of $13.99. GuruFocus considers Senseonics Holdings to be Possible Value Trap.

Key valuation signals for SENS:

  • Research & Development: $32.90 Mil
  • GF Value™: $13.99 vs. price of $5.72 (59.1% below fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the SENS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Senseonics Holdings Business Description

Other Exchanges 6L60:Germany
Address 20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
56GF Score

Get the complete analysis for SENS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.72
Price
$13.99
GF Value